Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Making Medicare Like Medicaid: High Anxiety For Drug Makers

Executive Summary

While there's no active proposal on the table in Congress for Medicare to adopt Medicaid-like pricing, given the US election year uncertainties and the current increased focus on drug pricing, analysts insisted that although such a scenario represented the worst case, it's the most reasonably realistic situation under which the government could try to rein in spending on prescription medicines.


Related Content

Analysts: Xtandi March-In Demands 'Noise,' 'Misguided'
PhRMA Condemns Medicare B Rx Drug Payment Experiment


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts